María José Mansilla

4PUBLICATIONS
7CO-AUTHORS
NanomedicineAutoimmunityMolecular targetsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 24, 2021
Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab.

Júlia Granell-Geli, Cristina Izquierdo-Gracia, Ares Sellés-Rius

|Dec 24, 2021
Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis.

Bibiana Quirant-Sánchez, María José Mansilla, Juan Navarro-Barriuso

|Jul 24, 2021
Transfection of Vitamin D3-Induced Tolerogenic Dendritic Cells for the Silencing of Potential Tolerogenic Genes. Identification of CSF1R-CSF1 Signaling as a Glycolytic Regulator.

María José Mansilla, Iñigo González-Larreategui, Neus Figa-Martín

|May 09, 2019
Optimal response to dimethyl fumarate is mediated by a reduction of Th1-like Th17 cells after 3 months of treatment.

María José Mansilla, Juan Navarro-Barriuso, Silvia Presas-Rodríguez

Pageof 1